249 related articles for article (PubMed ID: 17311802)
1. Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays.
Thomas RS; Pluta L; Yang L; Halsey TA
Toxicol Sci; 2007 May; 97(1):55-64. PubMed ID: 17311802
[TBL] [Abstract][Full Text] [Related]
2. A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays.
Thomas RS; O'Connell TM; Pluta L; Wolfinger RD; Yang L; Page TJ
Toxicol Sci; 2007 Mar; 96(1):40-6. PubMed ID: 17114358
[TBL] [Abstract][Full Text] [Related]
3. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
4. Use of short-term transcriptional profiles to assess the long-term cancer-related safety of environmental and industrial chemicals.
Thomas RS; Bao W; Chu TM; Bessarabova M; Nikolskaya T; Nikolsky Y; Andersen ME; Wolfinger RD
Toxicol Sci; 2009 Dec; 112(2):311-21. PubMed ID: 19776212
[TBL] [Abstract][Full Text] [Related]
5. Toxicogenomics applied to in vitro carcinogenicity testing with Balb/c 3T3 cells revealed a gene signature predictive of chemical carcinogens.
Rohrbeck A; Salinas G; Maaser K; Linge J; Salovaara S; Corvi R; Borlak J
Toxicol Sci; 2010 Nov; 118(1):31-41. PubMed ID: 20713471
[TBL] [Abstract][Full Text] [Related]
6. Prediction of carcinogenic potential by a toxicogenomic approach using rat hepatoma cells.
Tsujimura K; Asamoto M; Suzuki S; Hokaiwado N; Ogawa K; Shirai T
Cancer Sci; 2006 Oct; 97(10):1002-10. PubMed ID: 16918996
[TBL] [Abstract][Full Text] [Related]
7. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
[TBL] [Abstract][Full Text] [Related]
8. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
9. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
10. Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer.
Moriya Y; Iyoda A; Kasai Y; Sugimoto T; Hashida J; Nimura Y; Kato M; Takiguchi M; Fujisawa T; Seki N; Yoshino I
Lung Cancer; 2009 Apr; 64(1):86-91. PubMed ID: 18930562
[TBL] [Abstract][Full Text] [Related]
11. Identification of tumor promotion marker genes for predicting tumor promoting potential of chemicals in BALB/c 3T3 cells.
Maeshima H; Ohno K; Tanaka-Azuma Y; Nakano S; Yamada T
Toxicol In Vitro; 2009 Feb; 23(1):148-57. PubMed ID: 19000923
[TBL] [Abstract][Full Text] [Related]
12. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
[TBL] [Abstract][Full Text] [Related]
13. ADAM28: a potential oncogene involved in asbestos-related lung adenocarcinomas.
Wright CM; Larsen JE; Hayward NK; Martins MU; Tan ME; Davidson MR; Savarimuthu SM; McLachlan RE; Passmore LH; Windsor MN; Clarke BE; Duhig EE; Yang IA; Bowman RV; Fong KM
Genes Chromosomes Cancer; 2010 Aug; 49(8):688-98. PubMed ID: 20544843
[TBL] [Abstract][Full Text] [Related]
14. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases.
Mimori K; Fukagawa T; Kosaka Y; Ishikawa K; Iwatsuki M; Yokobori T; Hirasaki S; Takatsuno Y; Sakashita H; Ishii H; Sasako M; Mori M
Ann Surg Oncol; 2008 Oct; 15(10):2934-42. PubMed ID: 18661187
[TBL] [Abstract][Full Text] [Related]
15. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
[TBL] [Abstract][Full Text] [Related]
16. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
[TBL] [Abstract][Full Text] [Related]
17. Gene signature-based prediction of tumor response to cyclophosphamide.
Korrat A; Greiner T; Maurer M; Metz T; Fiebig HH
Cancer Genomics Proteomics; 2007; 4(3):187-95. PubMed ID: 17878522
[TBL] [Abstract][Full Text] [Related]
18. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
19. Validation of an in vitro screening test for predicting the tumor promoting potential of chemicals based on gene expression.
Maeshima H; Ohno K; Nakano S; Yamada T
Toxicol In Vitro; 2010 Apr; 24(3):995-1001. PubMed ID: 20025956
[TBL] [Abstract][Full Text] [Related]
20. Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma.
Nguyen ST; Hasegawa S; Tsuda H; Tomioka H; Ushijima M; Noda M; Omura K; Miki Y
Cancer Sci; 2007 May; 98(5):740-6. PubMed ID: 17391312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
